Corrigendum to “Results from three phase 1 trials of NNC9204-1177, a glucagon/GLP-1 receptor co-agonist: effects on weight loss and safety in adults with overweight or obesity” [Mol Metab 78 (2023) 101801]

Update your browser to view ScienceDirect.

Request details:

Request ID: 8c0f5a5bb9ce2349-LAX
IP: 116.62.10.13
UTC time: 2024-09-10T12:17:05+00:00
Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4